President Donald Trump on Tuesday signed a memorandum that aims to crack down on direct-to-consumer prescription drug ads, in a move that stops short of an outright ban.

The pharmaceutical industry's ability to advertise drugs directly to consumers has long been a target of Health and Human Services Secretary Robert F. Kennedy Jr., who floated a ban on those ads in November and has argued that they lead Americans to use more prescription medications. But senior administration officials on Tuesday said the new memorandum goes beyond drugmakers and traditional TV advertising by also targeting ads on social media and digital platforms.

The measure directs Kennedy and Food and Drug Administration Commissioner Marty Makary to take actions to ensure transparency and accuracy in drug advert

See Full Page